AU2001285981A1 - Biphenyl derivatives and their use as PPAR-GAMMA receptor activators - Google Patents

Biphenyl derivatives and their use as PPAR-GAMMA receptor activators

Info

Publication number
AU2001285981A1
AU2001285981A1 AU2001285981A AU2001285981A AU2001285981A1 AU 2001285981 A1 AU2001285981 A1 AU 2001285981A1 AU 2001285981 A AU2001285981 A AU 2001285981A AU 2001285981 A AU2001285981 A AU 2001285981A AU 2001285981 A1 AU2001285981 A1 AU 2001285981A1
Authority
AU
Australia
Prior art keywords
ppar
gamma receptor
biphenyl derivatives
receptor activators
activators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001285981A
Other versions
AU2001285981B2 (en
Inventor
Jean-Michel Bernardon
Laurence Clary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0010447A external-priority patent/FR2812876B1/en
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of AU2001285981A1 publication Critical patent/AU2001285981A1/en
Assigned to GALDERMA RESEARCH & DEVELOPMENT, S.N.C. reassignment GALDERMA RESEARCH & DEVELOPMENT, S.N.C. Amend patent request/document other than specification (104) Assignors: Refer to Publication History
Application granted granted Critical
Publication of AU2001285981B2 publication Critical patent/AU2001285981B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001285981A 2000-08-08 2001-08-03 Biphenyl derivatives and their use as PPAR-GAMMA receptor activators Ceased AU2001285981B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/10447 2000-08-08
FR0010447A FR2812876B1 (en) 2000-08-08 2000-08-08 NOVEL BIAROMATIC COMPOUNDS THAT ACTIVATE PPAR-GAMMA TYPE RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
PCT/FR2001/002543 WO2002012210A1 (en) 2000-08-08 2001-08-03 Biphenyl derivatives and their use as ppar-gamma receptor activators

Publications (2)

Publication Number Publication Date
AU2001285981A1 true AU2001285981A1 (en) 2002-05-16
AU2001285981B2 AU2001285981B2 (en) 2006-01-19

Family

ID=8853412

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001285981A Ceased AU2001285981B2 (en) 2000-08-08 2001-08-03 Biphenyl derivatives and their use as PPAR-GAMMA receptor activators
AU8598101A Pending AU8598101A (en) 2000-08-08 2001-08-03 Biphenyl derivatives and their use as ppar-gamma receptor activators

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU8598101A Pending AU8598101A (en) 2000-08-08 2001-08-03 Biphenyl derivatives and their use as ppar-gamma receptor activators

Country Status (20)

Country Link
US (1) US6927228B2 (en)
EP (1) EP1309575B1 (en)
JP (1) JP2004505958A (en)
KR (1) KR20030051611A (en)
CN (1) CN1468226A (en)
AR (1) AR032888A1 (en)
AT (1) ATE297386T1 (en)
AU (2) AU2001285981B2 (en)
BR (1) BR0113251A (en)
CA (1) CA2418895A1 (en)
DE (1) DE60111393T2 (en)
DK (1) DK1309575T3 (en)
ES (1) ES2245373T3 (en)
FR (1) FR2812876B1 (en)
MX (1) MXPA03001184A (en)
PL (1) PL360292A1 (en)
PT (1) PT1309575E (en)
RU (1) RU2280033C2 (en)
WO (1) WO2002012210A1 (en)
ZA (1) ZA200300667B (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI279401B (en) 1999-08-31 2007-04-21 Incyte San Diego Inc Heterocyclic derivatives for the treatment of diabetes and other diseases
WO2002072009A2 (en) 2001-03-07 2002-09-19 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
JP2004523571A (en) 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド RXR activating molecule
TWI311133B (en) 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
US20040152746A1 (en) * 2001-04-30 2004-08-05 Bardsley Hazel Judith Treatment of scarring and related conditions using ppar-gamma activators
JPWO2002098840A1 (en) * 2001-06-04 2004-09-16 エーザイ株式会社 Pharmaceuticals comprising carboxylic acid derivatives and their salts or esters
WO2003016267A1 (en) * 2001-08-17 2003-02-27 Incyte San Diego Incorporated Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
WO2003043998A1 (en) 2001-11-15 2003-05-30 Incyte San Diego Incorporated N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
HUP0501011A3 (en) 2001-12-14 2009-04-28 Novo Nordisk As Carbamates as hormone-sensitive lipase inhibitors, process for producing them, pharmaceutical compositions containing them and their use
US6908939B2 (en) 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
FR2833949B1 (en) * 2001-12-21 2005-08-05 Galderma Res & Dev NOVEL PPARy RECEPTOR ACTIVATION LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
FR2836683B1 (en) * 2002-03-01 2006-06-23 Galderma Res & Dev NOVEL PPARy RECEPTOR ACTIVATION LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
KR20050088992A (en) 2002-10-07 2005-09-07 더 리전트 오브 더 유니버시티 오브 캘리포니아 Modulation of anxiety through blockade of anandamide hydrolysis
CN1705645A (en) * 2002-10-24 2005-12-07 默克专利有限公司 Methylene urea derivatives as raf-kinase inhibitors
MXPA05005171A (en) * 2002-11-19 2005-10-26 Galderma Res & Dev Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions.
FR2847251B1 (en) * 2002-11-19 2006-11-17 NOVEL BI-AROMATIC ACTIVATED PPARy RECEPTOR-ACTIVE COMPOUNDS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
FR2847580B1 (en) * 2002-11-25 2006-03-03 Galderma Res & Dev NOVEL BI-AROMATIC RECEPTOR-ACTIVATING COMPOUNDS OF PPARy TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
AU2003294025A1 (en) * 2002-11-25 2004-06-18 Galderma Research & Development, S.N.C. Biphenyl compounds which activate PPAR-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
BR0316193A (en) 2002-12-12 2005-09-27 Galderma Res & Dev Compound, cosmetic composition, cosmetic use of a composition, use of a compound and pharmaceutical composition
FR2848553B1 (en) * 2002-12-12 2007-03-30 Galderma Res & Dev NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
WO2004066952A2 (en) * 2003-01-29 2004-08-12 Incyte Corporation Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
AU2004232326A1 (en) * 2003-04-18 2004-11-04 Incyte San Diego Incorporated Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
FR2856401B1 (en) * 2003-06-20 2010-02-12 Galderma Res & Dev NOVEL MODULATING COMPOUNDS OF PPARGAMMA RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
AU2004249430B2 (en) * 2003-06-20 2011-08-18 Galderma Research & Development, S.N.C. Novel compounds that modulate PPARgamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
FR2869903B1 (en) 2004-05-06 2006-06-23 Galderma Res & Dev NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPARY TYPE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
MXPA06012679A (en) 2004-05-06 2007-01-16 Galderma Res & Dev NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARgamma-TYPE RECEPTORS, THEIR PROCESS OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.
KR100619441B1 (en) * 2004-06-30 2006-09-08 서울옵토디바이스주식회사 Growth method of easy remove Sudstate
AU2005274277A1 (en) * 2004-08-17 2006-02-23 Galderma Research & Development, S.N.C. Novel biaromatic compounds which activate receptors of PPAR type and their use in cosmetic or pharmaceutical compositions
FR2874378B1 (en) * 2004-08-17 2006-10-27 Galderma Res & Dev NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPAR TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
FR2874379B1 (en) * 2004-08-17 2006-10-27 Galderma Res & Dev NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPAR TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
KR20070047308A (en) 2004-08-17 2007-05-04 갈데르마 리써어치 앤드 디벨로프먼트 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
FR2878247B1 (en) 2004-11-19 2008-10-03 Galderma Res & Dev NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
CA2587545C (en) * 2004-11-19 2013-10-22 Galderma Research & Development, S.N.C. Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
WO2006109085A1 (en) * 2005-04-13 2006-10-19 Astex Therapeutics Limited Hydroxybenzamide derivatives and their use as inhibitors of hsp90
FR2887444A1 (en) * 2005-06-28 2006-12-29 Oreal BENZYLIDENE-1,3-THIAZOLIDINE-2,4-DIONES COMPOUNDS, THEIR USES AND COMPOSITIONS FOR STIMULATING OR INDUCING THE PUSH OF KERATIN FIBERS AND / OR BRAKING THEIR FALL AND / OR INCREASING THEIR DENSITY
US20070059265A1 (en) * 2005-06-28 2007-03-15 L'oreal Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers
FR2892412B1 (en) * 2005-10-26 2008-05-16 Galderma Res & Dev BIAROMATIC COMPOUNDS MODULATORS OF PPARS
FR2897536A1 (en) * 2006-02-17 2007-08-24 Galderma Res & Dev USE OF MURAGLITAZAR FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
WO2008042892A2 (en) * 2006-10-02 2008-04-10 N.V. Organon Fatty acid amide hydrolase inhibitors for energy metabolism disorders
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
JP5721949B2 (en) 2006-10-12 2015-05-20 アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ Compound drug
WO2008044054A2 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Hydroxy-substituted benzoic acid amide compounds for use in therapy
US8779132B2 (en) 2006-10-12 2014-07-15 Astex Therapeutics Limited Pharmaceutical compounds
JP5528806B2 (en) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド Compound drug
US7803940B2 (en) 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
FR2917084B1 (en) * 2007-06-05 2009-07-17 Galderma Res & Dev NOVEL 3-PHENYL PROPANOIC ACID DERIVATIVES OF PPAR-TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
FR2917086B1 (en) * 2007-06-05 2009-07-17 Galderma Res & Dev NOVEL 3-PHENYL ACRYLIC ACIDIC ACID DERIVATIVES OF PPAR TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.
WO2009058298A1 (en) * 2007-10-31 2009-05-07 Merck & Co., Inc. P2x3, receptor antagonists for treatment of pain
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
EP2296664A1 (en) * 2008-04-15 2011-03-23 Burnham Institute for Medical Research An inhibitor of anti-apoptotic proteins
US9169238B2 (en) 2008-07-31 2015-10-27 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
MX2011008058A (en) 2009-01-30 2011-09-01 Takeda Pharmaceutical Fused ring compound and use thereof.
FR2969149B1 (en) * 2010-12-16 2012-12-28 Oreal PROCESS FOR DEPIGMENTING KERATINIC MATERIALS USING RESORCINOL DERIVATIVE COMPOUNDS
HUE026671T2 (en) 2011-08-18 2016-07-28 Nippon Shinyaku Co Ltd HETEROCYCLIC DERIVATIVE AS MICROSOMAL PROSTAGLANDIN E SYNTHASE (mPGEs) INHIBITOR
KR101485247B1 (en) * 2012-06-26 2015-01-22 중앙대학교 산학협력단 Novel biphenyl-3-carboxamide derivatives or salt thereof and pharmaceutical composition for treating or preventing autoimmune diseases comprising the same
MY189770A (en) 2014-12-24 2022-03-04 Lg Chemical Ltd Biaryl derivative as gpr120 agonists
CN118206542A (en) * 2023-03-22 2024-06-18 沈阳药科大学 Compound, preparation method thereof and application of compound in preparation of sEH inhibitor and PPARs agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100620337B1 (en) * 1998-03-10 2006-09-13 오노 야꾸힝 고교 가부시키가이샤 Carboxylic acid derivatives and drugs containing the same as the active ingredient
WO2003018011A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase

Similar Documents

Publication Publication Date Title
AU2001285981A1 (en) Biphenyl derivatives and their use as PPAR-GAMMA receptor activators
AU8598101A (en) Biphenyl derivatives and their use as ppar-gamma receptor activators
AU2002222001A1 (en) 3-arylindole derivatives and their use as CB2 receptor agonists
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2001248279A1 (en) New compounds, their preparation and use
HUP0203961A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001242523A1 (en) Aminophenyl pyrimidone derivatives
AU2001291744A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
AU2001227114A1 (en) Substituted cyanoacetamide derivatives and herbicides
AU2001277561A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AUPQ570100A0 (en) Beta-alanine derivatives and their use as receptor antagonists
AU4432001A (en) Trityl-type compounds and their use
AU3979700A (en) Use of osseo-promotive membranes in orthopaedics
AU2001277691A1 (en) Thermoinsulating knapsack
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU6270300A (en) Substituted heteroaryloxyacetanilides and their use as herbicides
AU2001282268A1 (en) Phenantridine derivatives and their use as anti-telomerase agent
AU8973201A (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU6286101A (en) New use
AU2002224772A1 (en) Morphinoid derivatives as delta-opioid agonists and antagonists
AU2001289732A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU2001274034A1 (en) 3-arylisothiazoles and their use as herbicides
AU2000266120A1 (en) Chimeric receptors and their uses